October 1, 2021 Neuro with Sir Gebrielle Hipolito PDF
Document Details
Uploaded by Deleted User
Tags
Summary
This document provides information on neurology, specifically Alzheimer's Disease. It covers the symptoms, risk factors, and possible causes. The document also details management strategies and interventions, including medical treatments and potential complications.
Full Transcript
10-01-21 NEURO WITH SIR GEBRIELLE 2) TEMPORAL LOBE (Wernicke’s Speech HIPOLITO Area / PROBLEM IN COMPREHENSION ALZHEIMER’S DISEASE - WERNICKE’S APHASIA OR RECEPTIVE...
10-01-21 NEURO WITH SIR GEBRIELLE 2) TEMPORAL LOBE (Wernicke’s Speech HIPOLITO Area / PROBLEM IN COMPREHENSION ALZHEIMER’S DISEASE - WERNICKE’S APHASIA OR RECEPTIVE APHASIA – Difficulty in understanding – - most common form of dementia spoken and written language - Cause: IDIOPATHIC / Unknown - Confusion, limited ability to comprehend Risk Factors: instructions especially when spoken - Advancing Age (average onset at 50 y/o - by family history Both types can exist simultaneously, known as - common in women GLOBAL or MIXED Aphasia This progressive memory loss will eventually lead to Aphasia- A – ABSENCE – Inability to communicate loss of cognition, coordination and muscle properly and coherently control Such progression leads to problems in breathing, where the client dies due to secondary complications like pneumonia - Neurotransmitter that is involved: LOW LEVELS OF ACETYLCHOLINE Hallmark Manifestation: - GRADUAL onset of RECENT MEMORY LOSS (ANTEROGRADE AMNESIA) - early onset - BEHAVIORAL CHANGES : Wandering as the disease progresses to EVEN LATER Behavior / hallucination – late progression STAGES: A – Ataxia – Inability to perform coordinated general movements (walking, running and sitting) - Uncoordinated movements which are jerky, leading to increased risk for injury C – Cognitive Changes – Impaired thought process: hallucinations/illusions - Aggressive behavior - Apathy Signs and Symptoms - Wandering behavior - (ALL OF THEM START WITH LETTER A – Atrophy of Muscles A!!!) - Leads to secondary complications such as A – Anterograde Amnesia (recent memory loss) PNEUMONIA, INCONTINENCE A – Agnosia (inability to recognize familiar and Diagnosis common objects) - Alzheimer’s is only confirmed via AUTOPSY A – Apraxia – (Instruct patient to button shirt, or tie only – the fact that they show these signs is shoe laces) – inability to do meaningful and intended only a consideration and autopsy is for movements CONFIRMATION - Presence of NEUROFIBRILLARY A – Aphasia – it depends – DAMAGE IN THE TANGLES in the brain tissue - Increase levels of TAU PROTEINS in nerve 1) FRONTAL LOBE, where the Broca’s tissue samples Speech area/ MOTOR movement is located – BROCA’S APHASIA or EXPRESSIVE Diagnostic Tools like: APHASIA - CT Scan, MRI, PET, Blood tests only serve - Difficulty in speaking and writing to rule out other causes of neurologic - Confusion, slurring and stuttering deficits 1) Recent Viral Illness - Influenza - Mononucleosis - Severe Acute respiratory Syndrome SARS-Cov2 (COVID-19) 2) Bacterial Infection - AGE r/t Campylobacter jejuni Management: 3) Vaccine Components Medications: to slow the progression of the - Influenza disease - HiB 1) Anti-cholinesterase - DOC: Donepezil (Aricept), Galantamine, Rivastigmine – medications that slow down the breakdown of ACETYLCHOLINE 2) Reminiscence Therapy - To stimulate the patient mentally 3) FOCUS IS SAFETY – SAFETY Signs and Symptoms - Never re-organize the environment around Hallmark Signs the patient - Avoid the use of extension cords - Associated with temporary, bilateral - Avoid throw rags ascending paralysis (starts at the toes up to - Ensure a well-lighted environment (use red, the neck) orange or yellow lights for elderly client) - Progression of paresis (weakness) to paralysis – 4) Complete vaccinations when it comes to TEMPORARY LOSS OF FUNCTION SUCH AS: FLU and PNEUMONIA Movement Bladder and bowel elimination Bloatedness due to gas distention Respiratory Failure (kasi nga neck down ang paralysis, the lungs will be impaired and it will pass) - OVERALL, THE PROGRESSION IS SELF-LIMITING - COMPLETE RECOVERY IS EXPECTED GUILLAN-BARRE SYNDROME (GBS) AFTER A FEW WEEKS, AS LONG AS THE CLIENT SURVIVES THE - Transient or Temporary neurologic deficit PROGRESSION stemming from an autoimmune response which results to transient polyradiculoneuropathy Polyradiculoneuropathy – Inflammatory response and damage to the nerves or spine which results to damage to the myelin sheath or axons (nerve fibers) Cause: - like most, IDIOPATHIC GBS TYPES Mechanism why it happened: AUTOIMMUNE 1) ACUTE INFLAMMATORY RESPONSE – the body attacks the nerves or the DEMYELINATING POLYNEUROPATHY spine tissue (AIDP) Triggers: - Most common variety of GBS (Ascending Paralysis) 4) MILLER-FISHER SYNDROM (MFS) variant - Presence of MOTOR DEFICITS (paralysis, of GBS weakness and atrophy of the muscles) Triad: - Presence of sensory deficits , sensation Ataxia (Paresis – weakness , numbness, tingling Areflexia sensation, inability to perceive pain and Opthalmoplegia – paralysis of eye muscles temperature changes) - This variety is associated with a recent infection of ZIKA VIRUS - Damage to the myelin sheath and axons - More common in men (nerve fibers) - Most cases do not feature limb paralysis or paresis (weakness) 2) ACUTE MOTOR AXONAL NEUROPATHY (ASCENDING PADIN) (AMAN) - PARALYSIS BUT SENSATION IS RETAINED - Most common variety in EAST ASIA - Associated with recent Campylobacter jejuni infection (AGE) - Presence of motor deficit (paralysis, weakness and atrophy) Diagnosis - SENSORY FUNCTION IS RETAINED AND 1) CT Scan, MRI, and PET Scan INTACT 2) CSF Analysis - Verify the presence of an inflammatory - Little to no damage to the myelin sheath response - Damage is focused on axons or nerve fibers ELEVATED PROTEIN LEVELS: Normal level: >>>>> PROGRESSIVE LOSS OF NEUROMUSCULAR FUNTCION Risk Factors 1) Progressive Degeneration of substantia nigra 2) Advancing age (50 y/o) 3) Recent Viral Illness (Mononucleosis, meningitis) especially in elders- trigger autoimmunity 4) Knots or clumps of alpha-synuclein (LEWY BODIES) in the sustantia nigra – genetic in nature inherited or FAMILY HISTORY 5) Neuroleptics – cause FALSE Parkinson’s or 4) POSTURAL CHANGES Pseudoparkinsonism (lowers Dopamine - Considered as late onset levels) - Formations of generalized stiffness from 6) Substantia nigra deterioration is more head to toe common in Males - client tends to waddle, shuffle and develop a 7) Overexposure to toxins or pesticides hunched back during movement or at rest 8) No absolute causation, the disease is 5) LOSS OF AUTOMATIC MOVEMENTS IDIOPATHIC - Considered as late onset - Inability to perform movements such as blinking, frowning, grimace and follow-up of swing-through arms when ambulating. - this leads to hypomimia: ALSO KNOWN AS MASKED FACE – inability to express facial movements and expression Signs and Symptoms - The diagnosis of Parkinson’s disease is based on the presence and progression of the 5 CARDINAL SIGNS eventually the progression will influence basic functions such as breathing, eating and 1) UNINTENTIONAL TREMORS – first elimination. This decreases quality of life, observed manifestation (EARLIEST) leading to complications such as pneumonia which is a common complication that leads to - Resting tremors, stronger and more defined mortality. at rest. Moving the body part minimizes such tremors - Also known as “pill rolling” 2) RIGIDITY Management: - Slow onset of stiffness which can be unilateral or bilateral 1) Priority: SAFETY - can appear anywhere but most commonly - simple activities seen on upper limbs - mild to moderate exercise such as aerobic and weight bearing exercise 3) BRADYKINESIA - Rubberized grips for spoons other utensils - Slow movement with unsteady gait - Avoiding clutter in the home environment - Client compensates by dragging the feet - raised toilet seats and handlebars in the instead of lifting them; creating what is bathroom known as a shuffling gait 2) Diet : SOFT - Limited to pureed, mashed and ground food items 3) RESPIRATORY FUNCTION 4) ATROPHY PREVENTION Medical Management 1) a - Amantadine 2) b – bromocriptine 3) c – carbidopa 4) d – dopar or levodopa 4 – DOPAR/LEVODOPA = DOC – MOST EFFE